Nebula Research & Development’s Medtronic MDT Stock Holding History

Nebula Research & Development’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,616	Closed	-$3.63M	–	518
2025 Q2	$3.63M	Sell	41,616 -10,572	-20%	-$897K	0.31%	63
2025 Q1	$4.69M	Buy	52,188 +10,818	+26%	+$968K	0.43%	16
2024 Q4	$3.3M	Buy	41,370 +33,934	+456%	+$2.94M	0.39%	29
2024 Q3	$669K	Sell	7,436 -25,721	-78%	-$2.16M	0.08%	457
2024 Q2	$2.61M	Buy	33,157 +23,084	+229%	+$1.89M	0.42%	13
2024 Q1	$878K	Sell	10,073 -6,214	-38%	-$530K	0.19%	178
2023 Q4	$1.34M	Buy	+16,287	New	+$1.24M	0.4%	43
2023 Q3	–	Sell	-7,126	Closed	-$628K	–	587
2023 Q2	$628K	Buy	+7,126	New	+$613K	0.48%	46

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nebula Research & Development's MDT Position: Q3 2025 in Review

Nebula Research & Development sold out of Medtronic (MDT) in Q3 2025, closing a stake of 41,616 shares — an estimated $3.63M sold.

Nebula Research & Development first reported a position in MDT in Q2 2023 and held it in 8 quarters. The position peaked at $4.69M in Q1 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

Nebula Research & Development reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
Nebula Research & Development sold 41,616 Medtronic shares in Q3 2025, an estimated $3.63M.
Nebula Research & Development first reported a position in Medtronic in Q2 2023 and held it in 8 quarters.
Nebula Research & Development's Medtronic position peaked at $4.69M in Q1 2025.
2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.